Please enable Javascript
Carlos Doti, MD
Carlos Doti, MD
Articles by Carlos Doti, MD
Dr. Carlos Doti Explains How AstraZeneca's Lynparza Has Impacted Oncology
Carlos Doti, MD
Breast Cancer News
|
March 26, 2025
Carlos Doti, MD, of AstraZeneca, discusses the impact of LYNPARZA over the last decade.
View More